Functions of the N-terminal region of cyclic nucleotide phosphodiesterase 3 (PDE 3) isoforms

被引:54
作者
Kenan, Y
Murata, T
Shakur, Y
Degerman, E
Manganiello, VC
机构
[1] NHLBI, Pulm Crit Care Med Branch, NIH, Bethesda, MD 20892 USA
[2] Lund Univ, Dept Cell & Mol Biol, Sect Mol Signalling, S-22100 Lund, Sweden
关键词
D O I
10.1074/jbc.275.16.12331
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The N-terminal portion of phosphodiesterase (PDE) 3 was arbitrarily divided into region 1 (amino acids 1-300), which contains a large hydrophobic domain with six predicted transmembrane helices, and region 2 (amino acids 301-500), with a smaller hydrophobic domain (similar to 50 residues). To analyze these regions, full-length human (H)PDE3A and mouse (M)PDE3B and a series of N-terminal truncated mutants were synthesized in Sf9 cells. Activities of HPDE3A, H3A-Delta 189, MPDE3B, and M3B-Delta 196, which retained all or part of the hydrophobic domain in region 1, were recovered almost entirely in particulate fractions. H3A-Delta 321 and M3B-Delta 302, containing region 2, were recovered essentially equally in particulate and cytosolic fractions. H3A-Delta 397 and H3A-Delta 457, lacking both hydrophobic domains, were predominantly cytosolic. H3A-Delta 510 and M3B-Delta 604, lacking both regions 1 and 2, were virtually completely cytosolic. M3B-Delta 196 eluted as a large aggregated complex during gel filtration. With removal of greater amounts of N-terminal sequence, aggregation of PDE3 decreased, and H3A-Delta 607, H3A-Delta 721, and M3B-Delta 604 eluted as dimers. Truncated HPDE3A proteins were more sensitive than full-length HPDE3A to inhibition by lixazinone. These results suggest that the hydrophobic domains in regions 1 and 2 contain structural determinants important for association of PDE3 with intracellular membranes, as well for self-association or aggregation during gel filtration and sensitivity to a specific inhibitor.
引用
收藏
页码:12331 / 12338
页数:8
相关论文
共 43 条
[1]  
AHMAD F, 2000, IN PRESS J IMMUNOL
[2]  
BARNETTE MS, 1995, J PHARMACOL EXP THER, V273, P674
[3]   Alternative splicing of cAMP-specific phosphodiesterase mRNA transcripts - Characterization of a novel tissue-specific isoform, RNPDE4A8 [J].
Bolger, GB ;
McPhee, I ;
Houslay, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :1065-1071
[4]   Human platelet cGI-PDE: Expression in yeast and localization of the catalytic domain by deletion mutagenesis [J].
Cheung, PP ;
Xu, H ;
McLaughlin, MM ;
Ghazaleh, FA ;
Livi, GP ;
Colman, RW .
BLOOD, 1996, 88 (04) :1321-1329
[5]   SINGLE-STEP AFFINITY PURIFICATION, PARTIAL STRUCTURE AND PROPERTIES OF HUMAN PLATELET CGMP INHIBITED CAMP-PHOSPHODIESTERASE [J].
DEGERMAN, E ;
MOOS, M ;
RASCON, A ;
VASTA, V ;
MEACCI, E ;
SMITH, CJ ;
LINDGREN, S ;
ANDERSSON, KE ;
BELFRAGE, P ;
MANGANIELLO, V .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 1994, 1205 (02) :189-198
[6]  
DEGERMAN E, 1987, J BIOL CHEM, V262, P5797
[7]   Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3) [J].
Degerman, E ;
Belfrage, P ;
Manganiello, VC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (11) :6823-6826
[8]   Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase [J].
Fisher, DA ;
Smith, JF ;
Pillar, JS ;
St Denis, SH ;
Cheng, JB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (25) :15559-15564
[9]   Cloning and characterization of a novel human phosphodiesterase that hydrolyzes both cAMP and cGMP (PDE10A) [J].
Fujishige, K ;
Kotera, J ;
Michibata, H ;
Yuasa, K ;
Takebayashi, S ;
Okumura, K ;
Omori, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (26) :18438-18445
[10]   PURIFICATION AND CHARACTERIZATION OF A HUMAN-PLATELET CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE [J].
GRANT, PG ;
COLMAN, RW .
BIOCHEMISTRY, 1984, 23 (08) :1801-1807